Expert Panel Discussion

The expert panel discussed the current use of Cerebrolysin in stroke and neurorehabilitation, focusing on whether it is delivering on its clinical promise. Experts highlighted positive clinical outcomes, growing guideline support and real-world evidence. The importance of combining Cerebrolysin with intensive, multidisciplinary rehabilitation was emphasized. Future directions included expanding indications (e.g., multiple sclerosis relapse, spontaneous hemorrhage, spinal cord injury) and the need for broader real-world data and updated clinical guidelines. The audience contributed actively to the discussion and asked several questions, including:

• In which indication do you think Cerebrolysin should be tested in addition to what we have already heard?
• Is there any disease or syndrome that promises to be tested with Cerebrolysin? Do you have an idea or preference?
• Is there experimental evidence for using Cerebrolysin in multiple sclerosis relapse?
• What would happen if we administer Cerebrolysin in the chronic stage (e.g., 3-month treatment cycles for chronic stroke patients)?

To gain further insight into the lively and dynamic discussion, please watch the full video.